About Arc Bio
Arc Bio is revolutionizing microbial detection by developing novel Next Generation Sequencing (NGS) solutions that allow for fast, accurate and cost-effective analysis. The Arc Bio Galileo™ platform enables accurate identification of virtually all microbes present in a primary sample in less than 30 hours.
Arc Bio is an EdenRoc Sciences Company based in Cambridge, Massachusetts with research and product development labs in the Bay Area.
“At Arc Bio, we are on a mission to change forever how infectious disease is diagnosed and managed. With our Galileo™ platform, we equip laboratorians with an entirely new standard of microbial detection capability through an integrated set of easy-to-use, cutting edge genomics tools. The future of infectious disease testing is accurate, comprehensive, unbiased sequencing. Galileo makes this a reality today.
Dr. Todd Dickinson, CEO, Arc Bio, LLC